Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06971913
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
SLE (Systemic Lupus)
CMV
Interventions
DRUG:
Interleukin-2 (IL-2)
DRUG:
Ganciclovir (GCV)
Sponsor
Peking University People's Hospital